Adolescent drug & alcohol use in the 21st century

Psychiatric Annals

Volumn 36, Issue 10, 2006, Pages 706-712

  Nanda, Sharmila ^a   Konnur, Neelam ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750942272     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Johnston LD, O'Malley PM., Bachman JG, Schulenberg JE. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings. Bethesda, MD: National Institute on Drug Abuse. 2004 NIH Publication No. 05-5726.
2. Kulig JW; American Academy of Pediatrics Committee on Substance Abuse. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse. Pediatrics. 2005;115(3):816-821.
3. Commonly Abused Drugs. National Institute on Drug Abuse. Available at: http://www.nida.nih.gov/DrugPages/DrugsOfAbuse.html. Accessed January 25, 2006.
4. Jenkins RR. Substance abuse. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 16th ed. Philadelphia, PA: WB Saunders Company; 2000:564-571.
5. Rogers PD, Adger H Jr. Alcohol and Adolescents. Adolesc Med. 1993;4(2):295-304.
6. American Academy of Pediatrics Committee on Substance Abuse. Alcohol use and abuse: a pediatric concern. Pediatrics. 2001;108(1):185-189.
7. Fishman M, Bruner A, Adger H Jr. Substance abuse among children and adolescents. Pediatr Rev. 1997;18(11):394-403.
8. Shuckit MA, Segal DS. Opioid drug use. In: Wilson JD, Braunwald E, Isselbacher KJ, et al. (eds.) Harrison's Principles of Internal Medicine, Volume 2. 12th ed. New York, NY: McGraw Hill; 1991:2551-2555.
9. Slade J. Adolescent Nicotine Use and Dependence. Adolesc Med. 1993;4(2):305-320.
10. O'Malley PM, Johnston LD, Bachman JG. Adolescent substance use and addictions: epidemiology, current trends, and public policy. Adolesc Med. 1993;4(2):227-248.
11. Brown RT, Coupey SM. Illicit drugs of abuse. Adolesc Med. 1993;4(2):321-340.
12. Heyman RB, Anglin TM, Copperman SM, et al; American Academy of Pediatrics Committee on Substance Abuse. Marijuana: a continuing concern for pediatricians. Pediatrics. 1999;104(4 Pt 1):982-985.
13. Dias PJ. Adolescent substance abuse. Assessment in the office. Pediatr Clin North Am. 2002;49(2):269-300.
14. NIDA Infofacts: Inhalants. National Institute on Drug Abuse. December 2004. Available at: http://www.nida.nih.gov/Infofacts/Inhalants.html. Accessed January 25, 2006.
15. Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician. 2003;68(5):869-874.
16. Schabner D. More and more children falling victim to meth. ABC News [ABC-News.com]. February 22, 2005. Available at: http://abcnews.go.com/Health/ OnCall/story?id=478222&page=1. Accessed January 25, 2006.
17. NIDA Infofacts: High School and Youth Trends. National Institute on Drug Abuse. December 2004. Available at: http://www.nida.nih.gov/infofacts/ HSYouthtrends.html. Accessed January 25, 2006.
18. Bravender T, Knight JR. Recent patterns of use and associated risks of illicit drug use in adolescents. Curr Opin Pediatr. 1998;10(4):344-349.
19. Ricaurte GA, McCann UD. Recognition and Recognition and management of complications of new recreational drug use. Lancet. 2005;365(9477):2137-2145.
20. Gahlinger PM. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine. Am Fam Physician. 2004;69(11):2619-2626.
21. Research Report Series - MDMA Abuse (Ecstasy). National Institute on Drug Abuse. February 4, 2005. Available at http://www.drugabuse.gov/researchreports/ MDMA/MDMA2.html. Accessed January 25, 2006.
22. Teter CJ, Guthrie SK. A comprehensive review of MDMA and GHB: two common club drugs. Pharmacotherapy. 2001;21(12):1486-513.
23. Simmons MM, Cupp MJ. Use and abuse of flunitrazepam. Ann Pharmacother. 1998;32(1):117-119.
24. Lankenau SE, Clatts MC. Patterns of polydrug use among ketamine injectors in New York City. Subst Use Misuse. 2005;40(9-10): 1381-1397.
25. Greydanus DE, Patel DR. Substance abuse in adolescents: a complex conundrum for the clinician. Pediatr Clin North Am. 2003;50(5):1179-223.
26. Research Report Series: Hallucinogens and Dissociative Drugs. National Institute on Drug Abuse. March 2001. Available at: http://www.nida.nih.gov/PDF/ RRHalluc.pdf. Accessed January 25, 2006.
27. Foley JD, Schydlower M. Anabolic steroid and ergogenic drug use by adolescents. Adolesc Med. 1993;4(2):341-352.
28. Clarkson PM, Thompson HS. Drugs and sport. Research findings and limitations. Sports Med. 1997;24(6):366-384.
29. Campos DR, Yonamine M, de Moraes Moreau RL. Marijuana as doping in sports. Sports Med. 2003;33(6):395-399.
30. Hawkins JD, Fitzgibbon JJ. Risk factors and risk behaviors in prevention of adolescent substance abuse. Adolesc Med. 1993;4(2):249-262.
31. Sterling S, Weisner C. Chemical dependency and psychiatric services for adolescents in private managed care: implications for outcomes. Alcohol Clin Exp Res. 2005;29(5):801-809.
32. Jovic-Vranes AS, Vranes B, Marinkovic J, Cucic V. Adolescent substance abuse, the importance of family, school and peers: data from the health behaviour in school children. Soz Praventivmed. 2005;50(2):119-124.
33. DuRant RH, Smith JA, Kreiter SR, Krowchuk DP. The relationship between early age of onset of initial substance use and engaging in multiple health risk behaviors among young adolescents. Arch Pediatr Adolesc Med. 1999;153(3):286-291.